Azenta Inc
$ 33.39
0.18%
11 Aug - close price
- Market Cap 1,536,273,000 USD
- Current Price $ 33.39
- High / Low $ 33.99 / 32.70
- Stock P/E N/A
- Book Value 34.51
- EPS -2.56
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.01 %
- ROE -0.07 %
- 52 Week High 41.73
- 52 Week Low 15.93
About
Azenta Inc. is a premier provider of sample management solutions and life science tools, dedicated to enhancing laboratory efficiencies within the biotechnology and pharmaceutical industries. The company excels in innovative automation and comprehensive biorepository services, facilitating faster drug discovery while ensuring adherence to stringent regulatory standards. With a forward-looking strategy that leverages advanced storage technologies and strategic partnerships, Azenta is uniquely positioned to seize growth opportunities in the expanding global life sciences market. Its commitment to pioneering scientific research through sophisticated innovations underscores its potential appeal to institutional investors seeking exposure in the dynamic life sciences sector.
Analyst Target Price
$34.80
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-04 | 2026-05-06 | 2026-02-04 | 2025-11-21 | 2025-08-05 | 2025-05-07 | 2025-02-05 | 2024-11-12 | 2024-08-06 | 2024-05-08 | 2024-02-07 | 2023-11-13 |
| Reported EPS | 0.16 | -0.04 | 0.09 | 0.21 | 0.19 | 0.05 | 0.08 | 0.18 | 0.16 | 0.05 | 0.02 | 0.13 |
| Estimated EPS | 0.1 | 0.14 | 0.13 | 0.2 | 0.14 | 0.07 | 0.06 | 0.11 | 0.07 | 0.02 | -0.03 | 0.02 |
| Surprise | 0.06 | -0.18 | -0.04 | 0.01 | 0.05 | -0.02 | 0.02 | 0.07 | 0.09 | 0.03 | 0.05 | 0.11 |
| Surprise Percentage | 60% | -128.5714% | -30.7692% | 5% | 35.7143% | -28.5714% | 33.3333% | 63.6364% | 128.5714% | 150% | 166.6667% | 550% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | None | None | None | None | None | None | None | None | None | None |
| Amount | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AZTA
2026-08-10 09:14:38
This article provides a list of ETFs that hold Azenta, Inc. stocks, detailing each fund's market value, weight of Azenta in its portfolio, issuer, management style, expense ratio, assets under management (AUM), price, change percentage, relative volume, and 3-year NAV total return. The information aims to make investing in Azenta through ETFs more accessible by highlighting diversified options with potentially lower risk.
2026-08-09 02:41:26
Glancy Prongay Wolke & Rotter LLP is continuing its securities fraud investigation into Azenta, Inc. (AZTA) on behalf of investors who lost money. The investigation follows Azenta's Q2 2026 financial results, which missed consensus estimates and led to a significant stock price drop after the company reduced its 2026 outlook and reported a goodwill impairment. Shareholders are urged to contact the firm to inquire about potentially pursuing claims.
2026-08-08 14:09:23
Glancy Prongay Wolke & Rotter LLP is continuing its investigation into Azenta, Inc. (NASDAQ: AZTA) for potential violations of federal securities laws. This follows a significant drop in Azenta's stock price after the company reported disappointing Q2 2026 financial results, including missing EPS and revenue estimates, recording a $149 million goodwill impairment, and reducing its 2026 outlook. Shareholders who incurred losses are encouraged to contact the law firm to learn about potentially pursuing claims.
2026-08-08 00:09:23
Quantinno Capital Management LP significantly reduced its stake in Azenta, Inc. (NASDAQ:AZTA) by 63.3% in the first quarter, selling over 391,000 shares and retaining 226,690 shares valued at approximately $4.79 million. Despite this, Azenta recently surpassed quarterly earnings expectations, reporting an adjusted EPS of $0.16 against a $0.11 consensus and revenue of $161.18 million. Analyst sentiment is mixed, with a consensus "Hold" rating and an average price target of $41.20, although Needham raised its target to $37.
2026-08-07 11:40:14
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Azenta, Inc. (NASDAQ: AZTA) on behalf of investors. This follows Azenta's Q2 2026 financial results, which missed consensus estimates for EPS and revenue, reported a $149 million goodwill impairment, and led to a reduced 2026 outlook. The firm encourages affected investors to contact them to assist with the investigation.
2026-08-07 00:09:24
Arrowstreet Capital Limited Partnership has acquired a new position in Azenta, Inc. (NASDAQ:AZTA), purchasing 71,410 shares valued at approximately $1.51 million, representing about 0.15% of the company. This comes as Azenta reported strong quarterly earnings, exceeding analyst estimates for both EPS and revenue, though it still maintains a negative net margin. Institutional investors hold a significant 99.08% stake in Azenta, and analyst sentiment is mixed but leaning positive, with Needham raising its price target to $37.
